Dr. Reddy's Laboratories Limited — Board Meeting, 23-01-2025: Outcome of Board Meeting

Dr. Reddy's Laboratories has announced a board meeting wherein the Board of Directors has approved the unaudited consolidated financial results for the quarter and nine months ended December 31, 2024. Key highlights include consolidated revenues of ₹83,586 Cr, reflecting a 16% year-on-year growth, and a net profit of ₹14,133 Cr, up 2% year-on-year. The company has integrated revenue from the recently acquired Nicotine Replacement Therapy business, which significantly contributed to the growth. Additionally, the gross profit margin for the quarter was reported at 58.7%.